Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
54,534 views
0 likes
|
Last Post
by Guest
11-06-2019, 05:43 AM
|
||
Started by ericapellossi, 12-31-2018, 02:14 AM
|
0 responses
6 views
0 likes
|
Last Post 12-31-2018, 02:14 AM | ||
Started by debasishbk, 12-24-2018, 02:09 AM
|
0 responses
2,505 views
0 likes
|
Last Post
by debasishbk
12-24-2018, 02:09 AM
|
||
Hello
by Kujin Kwon
Started by Kujin Kwon, 12-20-2018, 08:03 PM
|
0 responses
2,093 views
0 likes
|
Last Post
by Kujin Kwon
12-20-2018, 08:03 PM
|
||
Started by enrikk7, 12-14-2018, 05:28 AM
|
0 responses
2,085 views
0 likes
|
Last Post
by enrikk7
12-14-2018, 05:28 AM
|
||
Started by citosina, 12-13-2018, 12:25 PM
|
0 responses
2,054 views
0 likes
|
Last Post
by citosina
12-13-2018, 12:25 PM
|
||
Started by ControlCcolon, 12-12-2018, 12:18 AM
|
1 response
2,966 views
0 likes
|
Last Post
by Guest
12-12-2018, 02:51 AM
|
||
Started by taliena, 12-10-2018, 02:33 PM
|
0 responses
2,773 views
0 likes
|
Last Post
by taliena
12-10-2018, 02:33 PM
|
||
New Member
by hiatus
Started by hiatus, 11-28-2018, 03:26 AM
|
1 response
2,533 views
0 likes
|
Last Post
by Wang Qing
11-28-2018, 04:13 AM
|
||
Started by smcneely, 04-12-2018, 06:25 AM
|
2 responses
2,815 views
0 likes
|
Last Post
by Wang Qing
11-27-2018, 03:10 AM
|
||
Started by seqance, 06-22-2018, 01:39 PM
|
1 response
2,953 views
0 likes
|
Last Post
by Rahele
11-26-2018, 01:54 AM
|
No topics found.
-
Page of 0
-
Filter
Webinars
Collapse
-
by seqadminJoin us for our insightful SEQanswers webinar "Harnessing NGS in Cancer Research." This session will feature a panel of scientists discussing...
-
Channel: Webinar Series
03-18-2024, 08:22 AM -
Recent Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-25-2024, 11:49 AM
|
0 responses
20 views
0 likes
|
Last Post
by seqadmin
04-25-2024, 11:49 AM
|
||
Started by seqadmin, 04-24-2024, 08:47 AM
|
0 responses
20 views
0 likes
|
Last Post
by seqadmin
04-24-2024, 08:47 AM
|
||
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
62 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|